| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/23/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Grant | Performance Share Unit | 35k | $0.00 | $0 | | 08/23/2023 |
| 06/06/2023 | scPharmaceuticals Inc. | SCPH | Grant | Stock Option (Right to Buy) | 17.3k | $11.71 | $202.6k | | 06/06/2023 |
| 05/11/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Payment of Exercise | Common Stock | 15k | $36.47 | $547.2k | | 05/11/2023 |
| 05/11/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Performance Share Unit | 31.2k | $0.00 | $0 | | 05/11/2023 |
| 05/04/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Grant | Performance Share Unit | 31.2k | $0.00 | $0 | | 05/04/2023 |
| 02/23/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Grant | Employee Stock Option (Right to Buy) | 280k | $38.60 | $10.8M | | 02/23/2023 |
| 02/16/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Grant | Performance Share Unit | 20k | $0.00 | $0 | | 02/16/2023 |
| 02/03/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 200 | $42.02 | $8.4k | | 02/02/2023 |
| 02/03/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 330 | $9.56 | $3.2k | | 02/02/2023 |
| 02/02/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 13.5k | $42.06 | $569.1k | | 02/02/2023 |
| 02/02/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 22.5k | $9.56 | $215.2k | | 02/02/2023 |
| 01/31/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 1.6k | $9.56 | $15.5k | | 01/31/2023 |
| 01/31/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 976 | $42.01 | $41k | | 01/31/2023 |
| 01/18/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 8.1k | $9.56 | $77.2k | | 01/18/2023 |
| 01/18/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 4.9k | $40.40 | $199.4k | | 01/18/2023 |
| 01/17/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 25.4k | $40.03 | $1M | | 01/17/2023 |
| 01/17/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 41.9k | $9.56 | $400.8k | | 01/17/2023 |
| 11/25/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 17.8k | $9.56 | $170.1k | | 11/23/2022 |
| 11/25/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 11.1k | $35.18 | $391.7k | | 11/23/2022 |
| 11/23/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 3.6k | $9.56 | $34.6k | | 11/23/2022 |
| 11/23/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 2.3k | $35.05 | $79.2k | | 11/23/2022 |
| 11/22/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 600 | $35.00 | $21k | | 11/22/2022 |
| 11/22/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 959 | $9.56 | $9.2k | | 11/22/2022 |
| 11/21/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 848 | $9.56 | $8.1k | | 11/21/2022 |
| 11/21/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 531 | $35.01 | $18.6k | | 11/21/2022 |
| 11/15/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 1.1k | $35.00 | $39k | | 11/15/2022 |
| 11/15/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Employee Stock Option (Right to Buy) | 1.8k | $9.56 | $17k | | 11/15/2022 |
| 09/14/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Common Stock | 5.9k | $0.00 | $0 | | 09/14/2022 |
| 09/14/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Common Stock | 1.4k | $33.75 | $46.6k | | 09/14/2022 |
| 09/14/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Stock Appreciation Right | 5.9k | $7.90 | $46.6k | | 09/14/2022 |
| 08/16/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Common Stock | 9.2k | $34.01 | $312.3k | | 08/16/2022 |
| 08/16/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Sale | Common Stock | 14.7k | $34.01 | $499.7k | | 08/16/2022 |
| 08/16/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Stock Appreciation Right | 39.5k | $7.90 | $312.3k | | 08/16/2022 |
| 08/16/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Common Stock | 39.5k | $0.00 | $0 | | 08/16/2022 |
| 08/15/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Exercise | Stock Appreciation Right | 46.6k | $7.90 | $367.9k | | 08/15/2022 |
|